|
Match
|
Document |
Document Title |
|
|
7332230 |
Multilayer preparation in film form, consisting of hydrophilic polymers, for the rapid release of active ingredients
A multilayer preparation in the form of films of hydrophilic polymers for rapid release of substances present in the film layers into liquid surroundings is characterized in that adjacent layers...
|
|
|
7323194 |
Hydrophilic antimicrobial composition for an air conditioner evaporator of a vehicle
The present invention relates to a hydrophilic antimicrobial coating composition for an air conditioner evaporator of a vehicle with improved durability. In one embodiment of the present invention,...
|
|
|
7229647 |
Chlorine dioxide gel and associated methods
A method of making a composition having the property of being able to store chlorine dioxide includes mixing an aqueous chlorine dioxide solution with a superabsorbent, water-soluble polymer that...
|
|
|
7115586 |
Non-inclusion cyclodextrin complexes
The invention provides a number of methods for enhancing the aqueous solubility of an active ingredient which is insoluble or sparingly soluble in water. In one preferred embodiment, solubilization...
|
|
|
7109255 |
Bioresorbable hydrogel compositions for implantable prostheses
Crosslinked compositions formed from water-insoluble copolymers are disclosed. These compositions are copolymers having a bioresorbable region, a hydrophilic region and at least two cross-linkable...
|
|
|
7105180 |
Stable galenic preparations comprising a benzimidazole and method for the production thereof
The invention relates to a novel benzimidazole formulation and to a process for its production. The benzimidazole formulation comprises a layer comprising the benzimidazole compound together with...
|
|
|
7101840 |
Polymeric drug formulations
A method of forming a polymeric drug formulation in which a water-soluble drug is blended with a water-insoluble tissue-compatible polymer that is miscible in the solid phase with the drug, and...
|
|
|
7084132 |
Artemisinins with improved stability and bioavailability for therapeutic drug development and application
A stable form of artemisinin wherein an artelinic acid or artesunic acid is complexed with cyclodextrin analogs, preferably, β-cyclodextrin. The complexed cyclodextrin artemisinin formulation...
|
|
|
7022740 |
Lubricious ophthalmic solutions
There are provided lubricious ophthalmic solutions having a pH of between about 7.0 and about 8.0, consisting essentially of an aqueous solution of from about 0.5–4% by weight of a monographed...
|
|
|
6899896 |
Hydrogel-driven layered drug dosage form
A controlled release dosage form for sertraline has a core comprising a sertraline-containing composition and a water-swellable composition wherein the water-swellable composition is in a separate...
|
|
|
6858216 |
Cosmetic agent containing 2-furanone derivatives
There is provided cosmetic agents containing 2-furanone derivatives for the treatment of skin and hair.
|
|
|
6828334 |
Fenofibrate-cyclodextrin inclusion complexes and their pharmaceutical composition
The present invention relates to pharmaceutical compositions containing fenofibrate in the form of an inclusion complex with cyclodextrin, having high dissolution profile and in vivo enhanced...
|
|
|
6818247 |
Ethylene vinyl alcohol-dimethyl acetamide composition and a method of coating a stent
A composition comprising an ethylene vinyl alcohol copolymer and a dimethyl acetamide solvent is provided for forming a coating on prostheses such as stents. The composition can include an active...
|
|
|
6800663 |
Crosslinked hydrogel copolymers
The present invention relates to crosslinked polymers, synthesized through ring-opening polymerization of ethylenically unsaturated epoxides, in combination with α-hydroxy acids using a...
|
|
|
6761903 |
Clear oil-containing pharmaceutical compositions containing a therapeutic agent
The present invention relates to pharmaceutical compositions and methods for improved solubilization of triglycerides and improved delivery of therapeutic agents. Compositions of the present...
|
|
|
6749869 |
Acidic aqueous chlorite teat dip providing shelf life, sanitizing capacity and tissue protection
The mastitis control teat dip composition of the invention provides rapid initial kill, a useful highly pseudoplastic rheology, a barrier/film-forming capacity, a unique antimicrobial composition...
|
|
|
6703011 |
Application of film forming technology to fragrance control release systems; and resultant fragrance control release systems
Described is a fragrance control release system which is an emulsifier-free, single phase, nonporous, continuous, permeable polymeric film having a substantially uniform thickness of from about 1...
|
|
|
6699510 |
Acidic aqueous chlorite teat dip with improved visual indicator stability, extended shelf life, sanitizing capacity and tissue protection
The mastitis control teat dip composition having a visible indicator aspect of the invention provides a softening, soothing, smoothing, relaxing property, a rapid initial kill, a useful highly...
|
|
|
6676971 |
Embolic compositions
Embolic compositions comprising macromers having a backbone comprising a polymeric backbone comprising units with a 1,2-diol or 1,3-diol structure, such as polyvinyl alcohol, and pendant chains...
|
|
|
6660382 |
Process for manufacturing coated granules with masked taste and immediate release of the active principle
The invention concerns a method for making coated granules with masked taste and instant release of the active principle which consists in: first, mixing the constituents of a powder comprising at...
|
|
|
6652883 |
Tissue bulking and coating compositions
Compositions comprising macromers having a backbone comprising units having a 1,2-diol and/or 1,3-diol structure for tissue bulking and coating. Such polymers include poly(vinyl alcohol) (PVA) and...
|
|
|
6602915 |
Therapeutic azo-compounds for drug delivery
Polyazo compounds, which include low molecular weight drugs having a carboxylic acid group and an amine, thiol, alcohol or phenol group within their structure, formed into polymeric drug delivery...
|
|
|
6592859 |
Controlled expansion sphincter augmentation media
A composition for injecting into tissues surrounding the urethra or ureter. It comprises a plurality of physiologically acceptable solid polymer particles dispersed in a physiologically acceptable...
|
|
|
6589511 |
Composition for forming solid particles
The composition for forming solid particles of the present invention comprises a biodegradable polymer, a solvent, a polyhydric alcohol, a viscosity-increasing agent, and an active drug, wherein...
|
|
|
6562331 |
Mating disruption methods for the control of insect pests
A mating disruption method for the control of insect pests comprises releasing a sex pheromone in a field wherein an adsorption of the sex pheromone to a soil in the field is decreased.
|
|
|
6562330 |
Therapeutic use of polymers
An insoluble polymer is deposited in a body cavity for instance to embolize a vein or pack an aneurysm, the polymer having pendant zwitterionic groups to improve biocompatibility. The insoluble...
|
|
|
6538039 |
Pharmaceutical dosage form for transdermal administration
The present invention relates to a process for administering an active principle to a patient transdermally, which comprises the formation of a film on the patient's skin, by applying to the skin a...
|
|
|
6528086 |
Methods and apparatus for drug delivery involving phase changing formulations
This invention relates to an apparatus and method of drug delivery on a human body surface. The formulation comprises a drug, a conversion agent capable of converting the formulation from a less...
|
|
|
6503954 |
Biocompatible carrier containing actinomycin D and a method of forming the same
A biocompatible carrier and a composition for forming the carrier are disclosed. The carrier is made from an ethylene vinyl alcohol copolymer which can serve as a reservoir, allowing for the local...
|
|
|
6495163 |
Moisture barrier film coating composition, method and coated form
A dry moisture barrier film coating composition for forming a moisture barrier film coating for pharmaceutical tablets and the like comprises polyvinyl alcohol, soya lecithin, and optionally a flow...
|
|
|
6462093 |
Method for converting sparingly water-soluble medical substance to amorphous state
A process for producing a solid dispersion of a sparingly water-soluble medical substance which comprises subjecting the sparingly water-soluble medical substance, an amorphous state-inducing agent...
|
|
|
6451348 |
Method of manufacturing porous matrix-type controlled release systems using emulsion technique
A method of manufacturing a porous matrix-type drug delivery system is provided. It comprises the steps of: dispersing, stirring, and emulsifying an aqueous solution of a drug in an organic solvent...
|
|
|
6436440 |
Use of N-vinyllactam-or-N-vinylamine-containing copolymers as matrix for producing solid pharmaceutical and cosmetic presentations
The use of copolymers comprising a) 50 to 99% by weight of at least one N-vinyllactam or N-vinylamine selected from the group consisting of N-vinylpyrrolidone, N-vinylpiperidone,...
|
|
|
6432426 |
Non-staining topical iodine composition and method
Non-staining topical iodine disinfecting compositions having the ability to inactivate pathogens associated with skin infections or diseases. based upon the presence of molecular iodine in a...
|
|
|
6423307 |
Bioadhesive complexes of polycarbophil and azole antifungal or antiprotozoal drugs
Mucoadhesive antimicrobial complexes of polycarbophil, i.e. a cross-linked polyacrylic acid with bioadhesive properties, and an imidazole or triazole derivative with antifungal or antiprotozoal...
|
|
|
6413537 |
Nystatin formulation having reduced toxicity
The present invention provides a novel formulation of nystatin for parenteral administration to treat systemic fungal infections. The formulation avoids the toxicity and solubility problems of...
|
|
|
6395311 |
Multicomponent biological vehicle
The present invention provides a novel vehicle for the delivery of biologically active agents. The vehicle, Maxcell™, is formulated from a novel combination of natural plant extracts and is...
|
|
|
6383515 |
Solvent system for enhancing solubility
A pharmaceutically acceptable solution with a medicament suitable for filling a soft gelatin capsule is made from a solvent. The solvent contains a polymer, such as polyethylene glycol, and an acid...
|
|
|
6350471 |
Tablet comprising a delayed release coating
The invention provides a delayed release tablet, comprising: (i) a core comprising an active ingredient selected from the group consisting of oxybutynin hydrochloride, propranolol hydrochloride,...
|
|
|
6346273 |
Process for solubilizing pharmaceutically active ingredients in water and in aqueous vehicles
A process for solubilizing in water and in aqueous vehicles sparingly water-soluble pharmaceutically active substances, comprising the following operations: 1) forming a complex of the...
|
|
|
6284803 |
Solid dosage form with polymeric binder
The present invention relates to a solid dosage form comprising at least one polymeric binder and at least one active ingredient and, where appropriate, conventional additives, wherein the...
|
|
|
6280748 |
Cosmetic raw material cosmetic product and method for manufacturing cosmetic products
A cosmetic raw material possesses excellent compounding stability in cosmetic products. The cosmetic raw material is produced from a vinyl-type polymer having a carbosiloxane dendrimer structure in...
|
|
|
6274173 |
Oral pharmaceutical composition with delayed release of active ingredient for pantoprazole
An oral pharmaceutical composition comprises an acid-labile irreversible proton pump inhibitor in pellet or tablet form, wherein the irreversible proton pump inhibitor is at least partly in...
|
|
|
6267985 |
Clear oil-containing pharmaceutical compositions
The present invention relates to pharmaceutical compositions and methods for improved solubilization of triglycerides and improved delivery of therapeutic agents. Compositions of the present...
|
|
|
6251423 |
Sterilizable paste product for topical application
A paste or cream formulation which can be sterilised comprises an emulsion formed of a wax or oil, an emulsifier and water and an insoluble material which forms a gel in the presence of water. A...
|
|
|
6228354 |
Water resistant film-forming antimicrobial skin-preparation
A water-resistant, film-forming topical antimicrobial composition, removable by high pH solution, made in accordance with the principles of the present invention includes a polyvinyl lactam, a...
|
|
|
6210709 |
Flexible gelatin free encapsulation material useful for pharmaceuticals, paint balls and other formulations
A flexible capsule formed from a modified starch free of animal based gelatin. The invention provides a novel capsule defining a closed interior chamber, the capsule being formulated from a...
|
|
|
6194000 |
Analgesic immediate and controlled release pharmaceutical composition
Disclosed is a method for the therapeutic treatment of pain related to wind up in a human or animal. The method of the invention is practiced by administering to the subject an effective amount of...
|
|
|
6180133 |
Antioxidant composition for topical/transdermal prevention and treatment of wrinkles
An anti-wrinkle skin treating composition comprises a pressure sensitive matrix patch having dissolved in the adhesive a mixture of antioxidants in the form of a Vitamins C ester and Vitamin E....
|
|
|
6160025 |
Liquid embolic agents
This relates to a composition of matter comprising partially hydrolyzed polyvinyl acetate solutions suitable for use as embolic agent precursors. In addition, a procedure for introducing the...
|